The results argue that, unlike the role in leukemogenesis [24, 25], Mer expression is more likely a propagating (passenger) factor than a driver factor in the oncogenesis of NSCLC, which is also supported by few of activating mutation of Mer in NSCLC and other cancers [26, 27]. The gene discussed is MERTK; the disease is non-small cell lung carcinoma.